Although 21 patients had chronic kidney disease (CKD), admission NT‐proBNP levels were not significantly different among those without CKD, with CKD Stages 2–3, or with CKD Stages 4–5 (p = .368 by Kruskal–Wallis). This evidence concerns the gene NPPB and chronic kidney disease.